Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 2:13:912343.
doi: 10.3389/fneur.2022.912343. eCollection 2022.

A New Paradigm in Parkinson's Disease Evaluation With Wearable Medical Devices: A Review of STAT-ONTM

Affiliations
Review

A New Paradigm in Parkinson's Disease Evaluation With Wearable Medical Devices: A Review of STAT-ONTM

Daniel Rodríguez-Martín et al. Front Neurol. .

Abstract

In the past decade, the use of wearable medical devices has been a great breakthrough in clinical practice, trials, and research. In the Parkinson's disease field, clinical evaluation is time limited, and healthcare professionals need to rely on retrospective data collected through patients' self-filled diaries and administered questionnaires. As this often leads to inaccurate evaluations, a more objective system for symptom monitoring in a patient's daily life is claimed. In this regard, the use of wearable medical devices is crucial. This study aims at presenting a review on STAT-ONTM, a wearable medical device Class IIa, which provides objective information on the distribution and severity of PD motor symptoms in home environments. The sensor analyzes inertial signals, with a set of validated machine learning algorithms running in real time. The device was developed for 12 years, and this review aims at gathering all the results achieved within this time frame. First, a compendium of the complete journey of STAT-ONTM since 2009 is presented, encompassing different studies and developments in funded European and Spanish national projects. Subsequently, the methodology of database construction and machine learning algorithms design and development is described. Finally, clinical validation and external studies of STAT-ONTM are presented.

Keywords: Parkinson's disease; accelerometer; machine learning (ML); medical device; wearables.

PubMed Disclaimer

Conflict of interest statement

DR-M, JCab, CP-L, AC, AS, JCal, MP, and AR-M are shareholders of Sense4Care, the company that markets STAT-ON. DR-M, JCal, MP, and CC are employed by Sense4Care.

Figures

Figure 1
Figure 1
Windowing of a signal at 50% overlapping and feature extraction.
Figure 2
Figure 2
STAT-ONTM and its location and orientation.
Figure 3
Figure 3
STAT-ONTM′s internal structure.
Figure 4
Figure 4
Power system and regulator managing.
Figure 5
Figure 5
An example of the distribution of symptoms (hourly distribution of symptoms along different days following the established color code), one of the graphics generated by STAT-ONTM. This patient has a concurrent OFF zone every day around 18:00. It is clear when the patient rests at 15:00 or 16:00 every day. The OFF and dyskinesia are significant, but the FoG only appears 4 times, being practically insignificant and should be contrasted with the patient. The black line is when the button was pushed, in this case when the patient took the medication.
Figure 6
Figure 6
An example of the percentage of OFF hours and total OFF hours and the number of FoG episodes per day.
Figure 7
Figure 7
A stride fluidity example.
Figure 8
Figure 8
Some graph examples of the extended report.

References

    1. Maserejian N, Vinikoor-Imler L, Dilley A. Estimation of the 2020 Global Population of Parkinson's Disease (PD). International Congress of Parkinson's Disease and Movement Disorders. (2020) In: https://www.mdsabstracts.org/abstract/estimation-of-the-2020-global-popu...
    1. Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. (2018) 8:S3–8. 10.3233/JPD-181474 - DOI - PMC - PubMed
    1. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. (2008) 79:368–76. 10.1136/jnnp.2007.131045 - DOI - PubMed
    1. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs. (2007) 21:677–92. 10.2165/00023210-200721080-00005 - DOI - PubMed
    1. Lees a J. The on-off phenomenon. J Neurol Neurosurg Psychiatry. (1989) Suppl:29–37. 10.1136/jnnp.52.Suppl.29 - DOI - PMC - PubMed